Efficacy and Safety of Darunavir and Lopinavir in Treating HIV in Pediatric and Adolescent Populations: A Systematic Review - Top-Institutions - MDSpire

Efficacy and Safety of Darunavir and Lopinavir in Treating HIV in Pediatric and Adolescent Populations: A Systematic Review

  • By

  • John O’Rourke

  • Claire L. Townsend

  • Edith Milanzi

  • Hannah Castro

  • Intira Jeannie Collins

  • Ali Judd

  • Julie Jesson

  • Valériane Leroy

  • Martina Penazzato

  • Marissa Vicari

  • Françoise Renaud

  • April 3, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Pediatric Infectious Diseases
    • HIV/AIDS Research
    • Clinical Pharmacology
  • #2

    University of Cape Town
    University of Cape Town

    Cape Town, Western Cape

    Key Differentiators

    • Pediatric HIV Research
    • Global Health
    • Antiretroviral Therapy
  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Pediatric Infectious Diseases
    • HIV Clinical Trials
    • Pharmacology
  • #4

    Imperial College London
    Imperial College London

    London, England

    Key Differentiators

    • Pediatric HIV
    • Clinical Pharmacology
    • Global Health
  • #5

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Pediatric HIV Research
    • Clinical Trials
    • Pharmacology

Original Source(s)

Related Content